IL69450A - 2-methyl-8-lysergyl aryl ethers and thioethers,their production and pharmaceutical compositions containing them - Google Patents

2-methyl-8-lysergyl aryl ethers and thioethers,their production and pharmaceutical compositions containing them

Info

Publication number
IL69450A
IL69450A IL69450A IL6945083A IL69450A IL 69450 A IL69450 A IL 69450A IL 69450 A IL69450 A IL 69450A IL 6945083 A IL6945083 A IL 6945083A IL 69450 A IL69450 A IL 69450A
Authority
IL
Israel
Prior art keywords
lysergyl
thioethers
methyl
production
pharmaceutical compositions
Prior art date
Application number
IL69450A
Other languages
English (en)
Other versions
IL69450A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL69450A0 publication Critical patent/IL69450A0/xx
Publication of IL69450A publication Critical patent/IL69450A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL69450A 1982-08-09 1983-08-08 2-methyl-8-lysergyl aryl ethers and thioethers,their production and pharmaceutical compositions containing them IL69450A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.

Publications (2)

Publication Number Publication Date
IL69450A0 IL69450A0 (en) 1983-11-30
IL69450A true IL69450A (en) 1986-10-31

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69450A IL69450A (en) 1982-08-09 1983-08-08 2-methyl-8-lysergyl aryl ethers and thioethers,their production and pharmaceutical compositions containing them

Country Status (23)

Country Link
JP (1) JPS5948480A (fr)
AT (1) AT383125B (fr)
AU (1) AU563736B2 (fr)
BE (1) BE897473A (fr)
CA (1) CA1215972A (fr)
CH (1) CH649998A5 (fr)
DE (1) DE3327705A1 (fr)
DK (1) DK361983A (fr)
ES (1) ES8502992A1 (fr)
FI (1) FI73679C (fr)
FR (1) FR2531433B1 (fr)
GB (1) GB2125041B (fr)
GR (1) GR78923B (fr)
HU (1) HU187600B (fr)
IL (1) IL69450A (fr)
IT (1) IT1168961B (fr)
MY (1) MY8700166A (fr)
NL (1) NL8302776A (fr)
NZ (1) NZ205181A (fr)
PH (1) PH20385A (fr)
PT (1) PT77168B (fr)
SE (1) SE8304315L (fr)
ZA (1) ZA835850B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
FR2531433B1 (fr) 1985-10-18
SE8304315D0 (sv) 1983-08-08
GB2125041B (en) 1986-04-23
DE3327705A1 (de) 1984-02-09
CA1215972A (fr) 1986-12-30
ATA286383A (de) 1986-10-15
FI832789A0 (fi) 1983-08-02
ES524815A0 (es) 1985-02-01
IT1168961B (it) 1987-05-20
FI73679B (fi) 1987-07-31
PH20385A (en) 1986-12-08
HU187600B (en) 1986-01-28
MY8700166A (en) 1987-12-31
ZA835850B (en) 1985-03-27
AT383125B (de) 1987-05-25
IL69450A0 (en) 1983-11-30
CH649998A5 (de) 1985-06-28
FR2531433A1 (fr) 1984-02-10
DK361983D0 (da) 1983-08-08
ES8502992A1 (es) 1985-02-01
SE8304315L (sv) 1984-02-10
NZ205181A (en) 1986-07-11
IT8322490A0 (it) 1983-08-09
PT77168A (en) 1983-09-01
JPS5948480A (ja) 1984-03-19
GB2125041A (en) 1984-02-29
GR78923B (fr) 1984-10-02
AU563736B2 (en) 1987-07-23
NL8302776A (nl) 1984-03-01
PT77168B (en) 1986-03-27
DK361983A (da) 1984-02-10
FI73679C (fi) 1987-11-09
AU1767283A (en) 1984-02-16
FI832789A (fi) 1984-02-10
BE897473A (fr) 1984-02-06
GB8321222D0 (en) 1983-09-07

Similar Documents

Publication Publication Date Title
IL65056A0 (en) Imidazodiazepines,their manufacture and pharmaceutical compositions containing them
IL64315A (en) 1-sulfo-oxoazetidine derivatives,their production and pharmaceutical compositions containing them
IL69438A (en) Phenethanolamines,their manufacture and pharmaceutical compositions containing them
IL65167A0 (en) N-acyl-polypeptides,their production and pharmaceutical compositions containing them
IL64847A0 (en) Hexapyranose compounds,their manufacture and pharmaceutical compositions containing them
IL61971A (en) Polyether compounds x-14868,their manufacture and pharmaceutical compositions containing them
IL62960A0 (en) Imidazoazole compounds,their production and pharmaceutical compositions containing them
IL68323A0 (en) Phenoxyalkylcarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL69497A0 (en) Desoxyuridine derivatives,their production and pharmaceutical compositions containing them
IL68635A (en) Phenethanolamine derivatives,their manufacture and pharmaceutical compositions containing them
IL68576A0 (en) Azepinoindoles,their production and pharmaceutical compositions containing them
IL67284A (en) N-substituted-2-pyridylindoles,their manufacture and pharmaceutical compositions containing them
IL69540A0 (en) Polypeptides,their production and pharmaceutical compositions containing them
IL70324A0 (en) Ethers,their production and pharmaceutical compositions containing them
IL70189A0 (en) 2-piperazinyl-quinazoline derivatives,their production and pharmaceutical compositions containing them
IL69450A (en) 2-methyl-8-lysergyl aryl ethers and thioethers,their production and pharmaceutical compositions containing them
IL67813A0 (en) Benzothienylallylamines,their production and pharmaceutical compositions containing them
IL62167A0 (en) Phenoxy-aminopropanol derivatives,their manufacture and pharmaceutical compositions containing them
IL70229A0 (en) 2-penem derivatives,their manufacture and pharmaceutical compositions containing them
IL68508A0 (en) Pleuromutilin derivatives,their production and pharmaceutical compositions containing them
IL67715A0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives,their production and pharmaceutical compositions containing them
IL62592A0 (en) Phenyl-quinolizidines,their manufacture and pharmaceutical compositions containing them
IL63595A (en) Diaryl-imidazole compounds,their manufacture and pharmaceutical compositions containing them
IL63917A0 (en) 2-aminoimidazoles,their manufacture and pharmaceutical compositions containing them
IL62605A (en) 2-isoxazol-4-yl-3-aminoethyl-1h-indole derivatives,their production and pharmaceutical compositions containing them